Financials data is unavailable for this security.
View more
Year on year Perpetua Medical AB (publ) had relatively flat revenues (10.11m to 9.94m), though the company grew net income from a loss of 19.16m to a smaller loss of 18.28m. A reduction in the selling, general and administrative costs as a percentage of sales from 150.17% to 145.66% was a component in the net income growth despite flat revenues.
Gross margin | -65.03% |
---|---|
Net profit margin | -134.27% |
Operating margin | -139.12% |
Return on assets | -54.70% |
---|---|
Return on equity | -74.21% |
Return on investment | -74.20% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at Perpetua Medical AB (publ) fell by 5.16m. Cash Flow from Financing totalled 12.12m or 121.93% of revenues. In addition the company used 16.41m for operations while cash used for investing totalled 865.25k.
Cash flow per share | -0.0499 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.095 |
---|---|
Tangible book value per share | 0.095 |
More ▼
Balance sheet in SEKView more
Current ratio | 6.58 |
---|---|
Quick ratio | 6.39 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼